SuperworthSurrozen market cap SRZN
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $299.5M
- Highest close in our data
- $386M
- May 2026
Surrozen is worth $299.5M at the close on Oct 23, 2026, at $25.48 a share.
That is up 154% over the last year and up 258% over five years.
Its highest close in our data was $386M in May 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $299.5M | $158.5M | $386M | +57% |
| 2025 | $190.3M | $27.4M | $210.8M | +321% |
| 2024 | $45.2M | $15.5M | $45.2M | +136% |
| 2023 | $19.2M | $10.9M | $40M | −6% |
| 2022 | $20.4M | $15.6M | $188.8M | −91% |
| 2021 | $225.6M | $52.7M | $327.9M | n/a |
Against its peers
Companies in Biotechnology nearest Surrozen's size, closest first, today.
| Company | Market cap |
|---|---|
| SRZNSurrozen | $299.5M |
| PLXProtalix BioTherapeutics | $205.5M |
| MGTXMeiraGTx | $884.6M |
| VCELVericel | $2.2B |
| ADMAAdma Biologics | $2.4B |
| Peer median | $1.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Surrozen
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.